← Human Trials & Peer-Reviewed Studies
Comparison of a 'freeze-all' strategy including GnRH agonist trigger versus a 'fresh transfer' strategy including hCG trigger in assisted reproductive technology (ART): a study protocol for a randomised controlled trial
Plain-language guide to PMID 28760794 (2017): double-blind randomized controlled trial of hCG (human chorionic gonadotropin).
Key Facts
- PMID
- 28760794
- Journal
- BMJ open
- Year
- 2017
- Study type
- Randomized Controlled Trial
- Authors
- Stormlund S et al. (13 authors)
- DOI
- 10.1136/bmjopen-2017-016106
What This Study Did, in Plain Language
What Was Tested
This randomized controlled trial looks at hCG (human chorionic gonadotropin).
Thus, there is a need to test the concept against standard care in a randomised controlled design.
This study aims to compare ongoing pregnancy and live birth rates between a freeze-all strategy with gonadotropin-releasing hormone (GnRH) agonist triggering versus human chorionic gonadotropin (hCG) trigger and fresh embryo transfer in a multicentre randomised controlled trial.
The primary endpoint is to compare ongoing pregnancy rates per randomised patient in the two treatment groups after the first single blastocyst transfer.
Why It Was Studied
The study will be performed in accordance with the ethical principles in the Helsinki Declaration.
The study is approved by the Scientific Ethical Committees in Denmark and Sweden.
Who Took Part
The age groups tagged for this paper are young adults and adults, women only.
Multicentre randomised, controlled, double-blinded trial of women undergoing assisted reproductive technology treatment including 424 normo-ovulatory women aged 18-39 years from Denmark and Sweden.
Participants will be randomised (1:1) to either (1) GnRH agonist trigger and single vitrified-warmed blastocyst transfer in a subsequent hCG triggered natural menstrual cycle or (2) hCG trigger and single blastocyst transfer in the fresh (stimulated) cycle.
How the Study Was Run
The design is described as randomized, double-blind and multicenter.
The participants were allocated by chance, so the hCG (human chorionic gonadotropin) group and the comparison group should start out alike.
Blinding on both sides kept the participants and researchers unaware of who received hCG (human chorionic gonadotropin).
More than one site took part, so the participants came from several places.
What Was Measured
Topics PubMed links to this paper include Chorionic Gonadotropin, Cryopreservation, Denmark, Embryo Transfer, Gonadotropin-Releasing Hormone, Ovulation Induction and Pregnancy Rate.
The authors tagged it with the keywords ART, FET, Freeze-all, Ongoing pregnancy rate and RCT.
What This Means in Plain Language
The paper is a randomized, double-blind and multicenter study of hCG (human chorionic gonadotropin).
The publication is from 2017 (BMJ open), a journal based in England.
More context: the hCG (human chorionic gonadotropin) compound page, all human trials.
Our Notes on the Compound
hCG (human chorionic gonadotropin): An LH analog that drives Leydig-cell testosterone production.
Related Pages
Source: PubMed record. This explanation is written by PeptideWhiz from the public record. For research and education only. Not medical advice; no dosing information is given.